Comparative efficacy and safety results of two topical combination acne regimens

Journal of Drugs in Dermatology

Volumn 8, Issue 7, 2009, Pages 624-630

  Kircik, Leon H ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Physicians Skin Care PLLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMYCIN; BENZOYL PEROXIDE PLUS CLINDAMYCIN; CLINDAMYCIN PHOSPHATE PLUS RETINOIC ACID; MICROSPHERE; OXYGEN RADICAL; RETINOIC ACID; ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; DERMATOLOGICAL AGENT; KERATOLYTIC AGENT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BURN; BURNING SENSATION; CHILD; CLINICAL ASSESSMENT; COMEDO; COMPARATIVE STUDY; CONTACT DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; EYE SWELLING; FEMALE; FOLLICULAR KERATINIZATION; FOLLOW UP; HUMAN; KERATINIZATION; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; MICROCOMEDONE; MONOTHERAPY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAPULE; PATIENT COMPLIANCE; PROPIONIBACTERIUM ACNES; PRURITUS; PUSTULE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SKIN ABRASION; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; GEL; HOSPITALIZATION; INTRADERMAL DRUG ADMINISTRATION; MICROBIOLOGY; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CHILD; CLINDAMYCIN; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GELS; HUMANS; KERATOLYTIC AGENTS; MALE; PROPIONIBACTERIUM ACNES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TRETINOIN; YOUNG ADULT;

EID: 67651154693     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: Focus on antibiotic resistance. Cutis. 2007;79(suppl 6):9-25.
2. Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med. 2000;9(2):179-187.
3. Webster GF, McGinley KJ, Leyden JJ. Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol. 1981;104(4):453-457. (Pubitemid 11053493)
4. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline and erythromycin. Antimicrob Agents Chemother. 1982;21(5):770-772. (Pubitemid 12006526)
5. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol. 1978;70(1):51-55. (Pubitemid 8262275)
6. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-S38.
7. Melski JW, Arndt KA. Current concepts: Topical therapy for acne. New Engl J Med. 1980;302(9):503-506.
8. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology. 1998;196(1):119-125. (Pubitemid 28116058)
9. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: Combined results of two double-blind investigations. J Am Acad Dermatol. 1997;37(4):590-595. (Pubitemid 27446730)
10. Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24(7):1117-1133. (Pubitemid 34833234)
11. Chalker DK, Shalita A, Smith JG Jr, Swann RW. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol. 1983;9(6):933-936. (Pubitemid 14206988)
12. Mills OH Jr, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol. 1978;58(6):555-557. (Pubitemid 9125845)
13. Kircik L. Community-based trial results of combination clindamycin 1%-benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. Cutis. 2007;80(1 Suppl):10-14.
14. Ziana™ Prescribing Information. Scottsdale, Ariz: Medicis, The Dermatology Company;2006.
15. Draelos ZK. Patient compliance: Enhancing clinician abilities and strategies. J Am Acad Dermatol. 1995;32(5 Pt 3):S42-S48.
16. Wolf JE. Medication adherence: A key factor in effective management of rosacea. Adv Dermatol. 2001;18(6):272-281.